Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.
Open | $33.76 |
Close | $33.88 |
Volume / Avg. | 222.12K / 655.57K |
Day Range | 33.52 - 34.53 |
52 Wk Range | 23.14 - 35.56 |
Market Cap | $1.65B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 19.27% |
Days to Cover | 11.97 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.
Other companies in Mirum Pharmaceuticals’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Immatics (NASDAQ:IMTX), Kiniksa Pharmaceuticals (NASDAQ:KNSA), Bicycle Therapeutics (NASDAQ:BCYC) and BioCryst Pharma (NASDAQ:BCRX).
There is no analysis for Mirum Pharmaceuticals.
Mirum Pharmaceuticals has a consensus price target of $52.87.
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $34.9986 last updated July 3, 2024 at 1:24 PM EDT.
There are no upcoming dividends for Mirum Pharmaceuticals.
Mirum Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Mirum Pharmaceuticals.
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.